Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F5RAA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,974
Award facts
- Contract value 100% obligated
- $28,973.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,973.71 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on January 20, 2026, with completion expected by January 21, 2026. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant $999,999,999.00 IDC through December 2031 that serves as the comprehensive vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary pharmaceutical distribution operations.
This delivery order exemplifies the routine pharmaceutical procurement activities conducted through DLA's established medical supply chain, which ensures military treatment facilities and veteran healthcare programs maintain access to essential medications. Jardiance, an antidiabetic agent, is among the diverse therapeutic categories the company supplies under its IDC arrangement, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. As a major pharmaceutical distributor, AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill government medical procurement requirements through open competition, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5RAA?
SPE2DR26F5RAA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F5RAA worth?
The government has obligated $28,974 on SPE2DR26F5RAA.
Is contract SPE2DR26F5RAA an order under another contract?
Yes. SPE2DR26F5RAA is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5RAA competed?
The extent of competition for SPE2DR26F5RAA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award